Hyundai Bioscience, U.S. NIH to co-develop broad-spectrum antiviral drug
Hyundai Bioscience Co. said Sunday it will develop a broad-spectrum antiviral drug with the U.S. National Institutes of Health (NIH), a federal agency for conducting and supporting medical research.Hyundai Bioscience USA, a wholly owned subsidiary of …